Cargando…
Feasibility of recruitment to an oral dysplasia trial in the United Kingdom
BACKGROUND: Oral epithelial dysplasia (OED) has a malignant potential. Therapeutic options for OED remain both limited and without good evidence. Despite surgery being the most common method of treating OED, recurrence and potentially significant morbidity remain problematic. Consequently, there has...
Autores principales: | Nankivell, Paul, Dunn, Janet, Langman, Michael, Mehanna, Hisham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448506/ https://www.ncbi.nlm.nih.gov/pubmed/22731119 http://dx.doi.org/10.1186/1758-3284-4-40 |
Ejemplares similares
-
LIHNCS - Lugol’s iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol’s iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial
por: McCaul, James A, et al.
Publicado: (2013) -
Refeeding syndrome – awareness, prevention and management
por: Mehanna, Hisham, et al.
Publicado: (2009) -
Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
por: Payne, Karl, et al.
Publicado: (2023) -
Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia
por: Mahmood, Hanya, et al.
Publicado: (2023) -
Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia
por: Nankivell, P, et al.
Publicado: (2013)